Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit.
Am J Ophthalmol
; 141(2): 333-9, 2006 Feb.
Article
in En
| MEDLINE
| ID: mdl-16458690
ABSTRACT
PURPOSE:
To evaluate the outcome of sodium morrhuate 5% injections in patients with low flow vascular lesions, which consist of orbital lymphangiomas, and in one patient with intraosseous cavernous hemangioma.DESIGN:
Prospective, interventional consecutive case series.METHODS:
Intralesional sodium morrhuate 5% was injected under direct visualization or under radiographic guidance to six patients with orbital lymphangiomas and one patient with intraosseous cavernous hemangioma. Comprehensive eye examination and follow-up imaging studies were performed. main outcomemeasures:
Lesion size was evaluated by orbital imaging and clinical examination, visual acuity, exophthalmos, and posttreatment complications.RESULTS:
Seven patients (four female, three male; average age, 33 years) were included. Six patients were diagnosed with orbital lymphangioma, and one patient was diagnosed with intraosseous cavernous hemangioma. Patients received an average of 2.6+/-2 intralesional injections of sodium morrhuate, with a range of one to six injections and a mean volume of 0.9+/-0.8 ml (range, 0.2 to 2.1 ml). Lesions showed a decrease in size an average of 50% (33%) and ranged from minimal (10%) to near total resolution (85%). Visual acuity and intraocular pressure remained unchanged; exophthalmos decreased an average of 1.5+/-1.8 mm. Complications included one case of orbital hemorrhage that resolved spontaneously and transient keratopathy in all patients with anterior orbital lesions.CONCLUSION:
Intralesional sclerosing therapy with sodium morrhuate 5% is effective in tumor debulking in patients with orbital lymphangioma and is not associated with vision-threatening complications. It may be a better alternative to surgery for low flow orbital tumors, which includes lymphangioma.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sclerosing Solutions
/
Sodium Morrhuate
/
Orbital Neoplasms
/
Sclerotherapy
/
Lymphangioma
Type of study:
Diagnostic_studies
/
Guideline
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Ophthalmol
Year:
2006
Document type:
Article
Affiliation country:
United States